NEWTON ROGER S
Insider CIK 1242612 · ESPR Executive Chairman, CSO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics, Inc | S Sale | 2019-03-12 | 2019-03-14 | 25,000 | $50.06 | $1.25M | 548,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-02 | 2018-11-02 | 227 | $50.76 | $11.5K | 573,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-01 | 2018-11-02 | 2,600 | $50.01 | $130.0K | 573,953 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-10-18 | 2018-10-18 | 100 | $50.00 | $5.0K | 576,553 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-10-17 | 2018-10-18 | 12,673 | $50.02 | $633.9K | 576,653 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-10-16 | 2018-10-18 | 9,400 | $50.01 | $470.1K | 589,326 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-08-27 | 2018-08-29 | 4,200 | $51.46 | $216.1K | 610,826 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-08-27 | 2018-08-29 | 12,100 | $50.65 | $612.9K | 598,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-08-27 | 2018-08-29 | 700 | $53.68 | $37.6K | 615,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-08-27 | 2018-08-29 | 700 | $52.91 | $37.0K | 615,026 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-08-17 | 2018-08-22 | 7,300 | $50.06 | $365.4K | 616,426 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 10,100 | — | $0 | 10,100 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-03-29 | 2018-03-29 | 9,044 | $73.26 | $662.6K | 639,682 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-03-29 | 2018-03-29 | 7,100 | $71.36 | $506.7K | 623,926 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-03-29 | 2018-03-29 | 200 | $70.71 | $14.1K | 623,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-03-29 | 2018-03-29 | 8,656 | $72.31 | $625.9K | 631,026 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-02-07 | 2018-02-09 | 34,651 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-02-07 | 2018-02-09 | 34,651 | $6.99 | $242.2K | 652,334 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | F Tax w/h | 2018-02-07 | 2018-02-09 | 3,608 | $6.99 | $25.2K | 648,726 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | G Gift | 2017-12-12 | 2018-02-09 | 12,000 | — | $0 | 617,683 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-03-18 | 2015-03-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-01-02 | 2015-01-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2013-12-20 | 2014-02-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2013-07-23 | 2013-07-25 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 242,082 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 34,651 | — | $0 | 34,651 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 301,051 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 301,051 | — | $0 | 587,337 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 42,346 | $14.00 | $592.8K | 629,683 | SEC↗ |